ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,103,000 | -33.4% | 1,250,000 | -37.5% | 0.56% | -46.9% |
Q4 2018 | $1,655,000 | -51.0% | 2,000,000 | -50.0% | 1.06% | -31.1% |
Q3 2018 | $3,376,000 | -0.2% | 4,000,000 | +14.3% | 1.53% | +18.9% |
Q2 2018 | $3,382,000 | +86.0% | 3,500,000 | +75.0% | 1.29% | +89.1% |
Q1 2018 | $1,818,000 | -52.3% | 2,000,000 | -55.6% | 0.68% | -53.1% |
Q4 2017 | $3,811,000 | +5.6% | 4,500,000 | +12.5% | 1.45% | +12.6% |
Q3 2017 | $3,610,000 | +5.2% | 4,000,000 | 0.0% | 1.29% | -20.1% |
Q2 2017 | $3,433,000 | -57.5% | 4,000,000 | -57.9% | 1.62% | -55.4% |
Q1 2017 | $8,075,000 | +21.4% | 9,500,000 | +8.6% | 3.62% | -3.6% |
Q4 2016 | $6,650,000 | +48.2% | 8,750,000 | +59.1% | 3.76% | +33.6% |
Q3 2016 | $4,486,000 | +786.6% | 5,500,000 | +1000.0% | 2.81% | +1133.8% |
Q2 2015 | $506,000 | -87.6% | 500,000 | -87.5% | 0.23% | -89.9% |
Q1 2015 | $4,095,000 | -11.0% | 4,000,000 | 0.0% | 2.26% | -20.8% |
Q4 2014 | $4,603,000 | – | 4,000,000 | – | 2.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |